- Home
- NYXH
NYXH
Nyxoah SA
as 12-18-2024 12:40pm EST
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
| Founded: | 2009 | Country: | Belgium |
| Employees: | N/A | City: | N/A |
| Market Cap: | 261.1M | IPO Year: | 2021 |
| Target Price: | $17.00 | AVG Volume (30 days): | 37.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.00 - $20.00 | Next Earning Date: | 11-06-2024 |
| Revenue: | $5,668,079 | Revenue Growth: | 32.65% |
| Revenue Growth (this year): | 37.1% | Revenue Growth (next year): | 418.12% |
Latest Nyxoah SA News
NYXH Breaking Stock News: Dive into NYXH Ticker-Specific Updates for Smart Investing
Medical Device Network
2 days ago
Nyxoah introduces neurostimulator device for sleep apnoea in England
Design & Development Today
5 days ago
Tongue Implant Could Treat Sleep Apnea Without a CPAP
MT Newswires
5 days ago
Nyxoah Commercially Launches Genio Therapy in England; Shares Up Pre-Bell
GlobeNewswire
5 days ago
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
GlobeNewswire
21 days ago
Information on the total number of voting rights and shares
GlobeNewswire
a month ago
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire
a month ago
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
GlobeNewswire
a month ago
Publication relating to transparency notifications
Compare NYXH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NYXH Nyxoah SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.